Background Image
Table of Contents Table of Contents
Previous Page  35 / 74 Next Page
Information
Show Menu
Previous Page 35 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018

AFRICA

297

evaluate these parameters in terms of heart valve involvement

during the acute phase.

Methods

The authors assert that all procedures contributing to this work

comply with the ethical standards of the relevant national

guidelines on human experimentation and with the Helsinki

Declaration of 1975, as revised in 2008. The study was approved

by the institutional committee of Erciyes University. Detailed

consent forms were signed by the parents of all subjects before

participating in the study.

In this matched case–control study, 120 consecutive patients

diagnosed with ARC at the Department of Paediatric Cardiology

between February 2010 and March 2016, were enrolled in the

study. As the Jones criteria for the diagnosis of ARF were

modified in 2015,

15

older criteria had been used for the diagnosis

of earlier patients. A diagnosis of ARF was established when the

last Jones criteria were fulfilled for acute cases.

All patients underwent echocardiographic examination

before starting anti-inflammatory treatment. The Vivid 7 Pro

Ultrasound System (GE Medical Systems, NE) was used for

two-dimensional, M-mode and colour-flow Doppler imaging.

A paediatric cardiologist experienced in rheumatic heart disease

performed all echocardiographic examinations following the

guidelines of the American Society of Echocardiography and

European Society of Cardiology.

16

The severity of mitral and

aortic regurgitation detected by colour Doppler was defined

as mild, moderate and severe when the length of the jet was

>

1.5, 1.5–2.9 and

>

3 cm, respectively.

17

The patient group was

further divided into two subgroups according to the degree of

regurgitation, which included those with severe and those with

mild-to-moderate regurgitation.

Patients who had taken non-steroidal anti-inflammatory

drugs within the last four weeks before blood sampling, and those

with abnormal renal function or liver tests and malignancies

were excluded.

Arthritis and mild-to-moderate carditis were treated with

salicylate, whereas patients with severe carditis were treated

with oral prednisolone. Also, oral steroid therapy was started

in patients without discriminating between moderate and severe

carditis. Initially prednisolone (2 mg/kg/d) was given for two

weeks, which was then tapered off, and aspirin was started at

75–100 mg/kg/d (maximum dose 3.5 g/d) to prevent rebound.

Fifty age- and gender-matched healthy children were recruited

from the local population. They were referred to our hospital

because of cardiac murmur and underwent electrocardiography.

They had a negative medical history and no signs or symptoms

of acute or chronic disease. All participants in the control group

were examined by the same paediatrician and the results of the

physical examination were normal.

Full blood count parameters, anti-streptolysin-O (ASO),

erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)

titres and echocardiographic examinations of all subjects were

recorded from the same computerised database. Blood samples

were drawn from the peripheral veins and collected in plastic

tubes (Vacutainer-Becton, Dickinson and Co, USA), containing

dipotassium ethylene diamine tetra-acetic acid (EDTA-K2).

The full blood count analysis was done by flow cytometry

using the Abxpentra model 120 DX analyser in the laboratory

of our institution. NLR was calculated using the absolute count

method. ESR was determined with the Westergren method. ASO

(Rapitex ASL) and CRP titres were determined using standard

reagents on the Beckman-Coulter DXC 800 systems analyser in

the same laboratory.

Statistical analysis

Data are reported as mean ± standard deviation. If not normally

distributed, parameters are presented as median (range). The

distribution pattern of data was assessed with the Shapiro–

Wilks test. Differences between quantitative groups with normal

distribution were evaluated with the Student’s

t

-test. The Mann–

Whitney

U

-test was used for abnormally distributed data. The

associations between parameters were assessed using Pearson’s or

Spearman’s correlation tests. Statistical Package for Social Sciences

(SPSS) version 22.0 (SPSS Inc, Chicago, IL, USA) was used for all

statistical calculations. Beta- and

p

-values were assessed for each

independent factor in multiple linear regression analysis;

p

-values

<

0.05 were considered to be statistically significant.

Results

One hundred and twenty patients (72 female), who were

diagnosed with ARC, and 50 age- and gender-matched healthy

children were included in this study. The mean age of the patients

was 12.25 ± 2.89 (range: 7–18) years. Baseline clinical and

laboratory characteristics of patients and control subjects are

shown in Table 1.

Compared with the controls, ASO, CRP, ESR, haemoglobin,

white blood cell count (WBC), neutrophil count, MPV and NLR

values were significantly higher in patients with acute carditis

compared with the controls (

p

<

0.001) (Table 1). Also, platelet

counts (

p

=

0.002) and MPV (

p

=

0,049) values were significantly

higher in the patients. NLR was found to have a significantly

positive correlation with CRP (

r

=

0.177,

p

=

0.001), ESR (

r

=

Table 1. Demographic and laboratory characteristics

of the patient and control groups

Characteristics

Control (

n

=

50) ARF (

n

=

120)

p

-value

Age (years)

12.96 ± 2.55

12.25 ± 2.89

0.48

Males,

n

(%)

12

48

0.86

WBC count (× 10

3

cells/mm

3

)

7.02 ± 1.86

10.58 ± 3.76

<

0.01

Haemoglobin (g/dl)

13.60 ± 1.09

12.35 ± 1.03

<

0.01

ESR (mm/hour)

3.83 ± 2.57

37.12 ± 27.63

<

0.001

CRP (mg/l)

3.34 ± 0.54

46.37 ± 48.78

<

0.001

ASO (U/ml)

244.91 ± 239.62 995.24 ± 1023.69

<

0.001

Platelet count (× 10

3

cells/mm

3

) 291.30 ± 67.80

355.22 ± 103.3

0.002

MPV (fl)

10.21 ± 1.25

9.01 ± 1.35

<

0.003

RDW (%)

13.65 ± 1.30

12.88 ± 0.89

0.26

Neutrophil count

(× 10

3

cells/mm

3

)

3.64 ± 1.20

7.21 ± 3.56

<

0.001

Lymphocyte count

(× 10

3

cells/mm

3

)

2.64 ± 0.84

2.55 ± 0.84

0.67

NLR

a

1.35 (1.02–1.94) 3.73 (2.02–4.07)

<

0.001

MCV (fl)

82.95 ± 5.04

80.15 ± 6.01

0.06

ARF: acute rheumatic fever, ASO: anti-streptolysin-O, CRP: C-reactive protein,

ESR: erythrocyte sedimentation rate, MPV: mean platelet volume, WBC:

white blood cell, RDW: red blood cell distribution width, NLR: neutrophil-to-

lymphocyte ratio, MCV: mean corpuscular volume (fl).

Parametric values are expressed as means with standard deviation. Significance

is determined by

p

<

0.05 and shown in bold.

a

If not normally distributed,

values are presented as median and range in parentheses.